UBS Group’s ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN USML Stock Holding History

UBS Group’s Portfolio USML Stock Details USML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.49M	Buy	80,600 +3,499	+5%	+$147K	﹤0.01%	4540
2026 Q1	$3.1M	Buy	+77,101	New	+$3.26M	﹤0.01%	4564
2025 Q2	–	Sell	-100	Closed	-$4.24K	–	10854
2025 Q1	$4.24K	Buy	100 +59	+144%	+$2.42K	﹤0.01%	9129
2024 Q4	$1.57K	Buy	41 +11	+37%	+$452	﹤0.01%	9203
2024 Q3	$1.23K	Buy	+30	New	+$1.15K	﹤0.01%	8683
2022 Q3	–	Sell	-88	Closed	-$2K	–	10958
2022 Q2	$2K	Buy	+88	New	+$2.59K	﹤0.01%	9626

UBS Group's USML Position: Q2 2026 in Review

UBS Group increased its ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN (USML) stake by 4.5% in Q2 2026, buying an estimated $147K and bringing the position to 80,600 shares worth $3.49M. The position accounts for ﹤0.01% of the portfolio, ranked #4540.

UBS Group first reported a position in USML in Q2 2022 and has held it in 6 quarters since. 1 fund tracked by Wall St. Rank holds USML as of Q2 2026.

UBS Group held 80,600 shares of ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN worth $3.49M as of Q2 2026.
UBS Group bought 3,499 ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN shares in Q2 2026, an estimated $147K.
ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #4540 holding.
UBS Group first reported a position in ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN in Q2 2022 and has held it in 6 quarters since.
1 fund tracked by Wall St. Rank held ETRACS 2x Leveraged MSCI US Minimum Volatility Factor TR ETN as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.